Goldman Says Moderna Vaccine Filing May Be Sooner Than Expected

(Bloomberg) -- Moderna Inc. could file interim results on its Covid-19 vaccine candidate with U.S. regulators sooner than many investors are expecting, Goldman Sachs Group Inc. said.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.